# EDGAR Filing Document

**Accession Number:** 0000914775
**File Stem:** 0000940400-26-002274
**Filing Date:** 2026-1
**Character Count:** 47973
**Document Hash:** 4201dc212390d385a04a0a09d8b2176e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-002274.hdr.sgml**: 20260126

**ACCESSION NUMBER**: 0000940400-26-002274

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251130

**FILED AS OF DATE**: 20260126

**DATE AS OF CHANGE**: 20260126

**PERIOD START**: 20260831

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Advantage Funds, Inc.
- **CENTRAL INDEX KEY:** 0000914775

**ORGANIZATION NAME:**
- **EIN:** 133851784
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-07123
- **FILM NUMBER:** 26559330

**BUSINESS ADDRESS:**
- **STREET 1:** BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Advantage Funds, Inc.
- **DATE OF NAME CHANGE:** 20060502

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DREYFUS GROWTH & VALUE FUNDS INC
- **DATE OF NAME CHANGE:** 19951004

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DREYFUS FOCUS FUNDS INC
- **DATE OF NAME CHANGE:** 19940304

## Series and Classes Contracts Data

### BNY Mellon Dynamic Value Fund (Series ID: S000000498)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000001358 | Class A      | DAGVX           |
| C000001360 | Class C      | DCGVX           |
| C000001361 | Class I      | DRGVX           |
| C000130427 | Class Y      | DRGYX           |

## Nport-Ex

BNY Mellon Dynamic Value Fund

SCHEDULE OF INVESTMENTS

November 30, 2025 (Unaudited)

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 99.1%** | **Common Stocks — 99.1%** | **Common Stocks — 99.1%** |
| **Banks — 9.5%** | **Banks — 9.5%** | **Banks — 9.5%** |
| Bank of America Corp. | 5002000 | 268357300 |
| Citigroup, Inc. | 1926929 | 199629844 |
| First Horizon Corp. | 6757105 | 150953726 |
| JPMorgan Chase & Co. | 1132348 | 354515512 |
|  |  | **973456382** |
| **Capital Goods — 10.4%** | **Capital Goods — 10.4%** | **Capital Goods — 10.4%** |
| Carlisle Cos., Inc.<sup>(a)</sup> <br>| 180092 | 57281862 |
| Caterpillar, Inc. | 214881 | 123719885 |
| Cummins, Inc. | 146579 | 72993410 |
| Dover Corp. | 269993 | 50024303 |
| Emerson Electric Co. | 624744 | 83328355 |
| Ferguson Enterprises, Inc. | 294357 | 74080826 |
| Honeywell International, Inc. | 539271 | 103642494 |
| Howmet Aerospace, Inc. | 268722 | 54977834 |
| Hubbell, Inc. | 287055 | 123844139 |
| L3Harris Technologies, Inc. | 773470 | 215558354 |
| Northrop Grumman Corp. | 180788 | 103455933 |
|  |  | **1062907395** |
| **Commercial & Professional Services — .5%** | **Commercial & Professional Services — .5%** | **Commercial & Professional Services — .5%** |
| Veralto Corp. | 472526 | **47829082** |
| **Consumer Discretionary Distribution & Retail — 3.1%** | **Consumer Discretionary Distribution & Retail — 3.1%** | **Consumer Discretionary Distribution & Retail — 3.1%** |
| Amazon.com, Inc.<sup>(b)</sup> <br>| 918307 | 214167559 |
| Lowe's Companies, Inc. | 428165 | 103821449 |
|  |  | **317989008** |
| **Consumer Services — 1.5%** | **Consumer Services — 1.5%** | **Consumer Services — 1.5%** |
| Las Vegas Sands Corp. | 1479878 | 100868484 |
| Royal Caribbean Cruises Ltd. | 181344 | 48282840 |
|  |  | **149151324** |
| **Energy — 9.6%** | **Energy — 9.6%** | **Energy — 9.6%** |
| Diamondback Energy, Inc. | 734186 | 112029442 |
| EQT Corp. | 1855185 | 112906559 |
| Exxon Mobil Corp. | 2286839 | 265090377 |
| Marathon Petroleum Corp. | 1050525 | 203518208 |
| Permian Resources Corp. | 6830168 | 98969134 |
| Phillips 66 | 1377898 | 188716910 |
|  |  | **981230630** |
| **Equity Real Estate Investment Trusts — 1.0%** | **Equity Real Estate Investment Trusts — 1.0%** | **Equity Real Estate Investment Trusts — 1.0%** |
| Weyerhaeuser Co.<sup>(c)</sup> <br>| 4640026 | **103054977** |
| **Financial Services — 10.7%** | **Financial Services — 10.7%** | **Financial Services — 10.7%** |
| Berkshire Hathaway, Inc., Cl. B<sup>(b)</sup> <br>| 816802 | 419681036 |
| Capital One Financial Corp. | 479907 | 105133226 |
| CME Group, Inc. | 391877 | 110297700 |
| Morgan Stanley | 988672 | 167738092 |
| The Charles Schwab Corp. | 522525 | 48453743 |
| The Goldman Sachs Group, Inc. | 156345 | 129147224 |
| Voya Financial, Inc. | 1582732 | 111266060 |
|  |  | **1091717081** |

---

**3**

------

*SCHEDULE OF INVESTMENTS (Unaudited) (continued)*

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 99.1% (continued)** | **Common Stocks — 99.1% (continued)** | **Common Stocks — 99.1% (continued)** |
| **Health Care Equipment & Services — 8.8%** | **Health Care Equipment & Services — 8.8%** | **Health Care Equipment & Services — 8.8%** |
| Alcon AG | 878388 | 69664952 |
| Edwards Lifesciences Corp.<sup>(b)</sup> <br>| 843389 | 73096525 |
| Elevance Health, Inc. | 300705 | 101716473 |
| Humana, Inc. | 459670 | 112973096 |
| Labcorp Holdings, Inc. | 228486 | 61412467 |
| Medtronic PLC | 2816824 | 296696072 |
| UnitedHealth Group, Inc. | 540778 | 178332361 |
|  |  | **893891946** |
| **Household & Personal Products — 1.0%** | **Household & Personal Products — 1.0%** | **Household & Personal Products — 1.0%** |
| The Estee Lauder Companies, Inc., Cl. A | 1081080 | **101697195** |
| **Insurance — 6.1%** | **Insurance — 6.1%** | **Insurance — 6.1%** |
| American International Group, Inc. | 1396468 | 106355003 |
| Aon PLC, Cl. A | 600142 | 212402257 |
| Assurant, Inc. | 1329565 | 303353550 |
|  |  | **622110810** |
| **Materials — 7.0%** | **Materials — 7.0%** | **Materials — 7.0%** |
| Alcoa Corp. | 1567892 | 65443812 |
| CRH PLC | 1944389 | 233248904 |
| Freeport-McMoRan, Inc. | 3425496 | 147227818 |
| Newmont Corp. | 1756538 | 159370693 |
| Packaging Corp. of America | 551571 | 112559094 |
|  |  | **717850321** |
| **Media & Entertainment — 5.6%** | **Media & Entertainment — 5.6%** | **Media & Entertainment — 5.6%** |
| Alphabet, Inc., Cl. A | 782640 | 250585675 |
| Meta Platforms, Inc., Cl. A | 117395 | 76066090 |
| Omnicom Group, Inc.<sup>(a)</sup> <br>| 2155583 | 154382855 |
| The Walt Disney Company | 848610 | 88654287 |
|  |  | **569688907** |
| **Pharmaceuticals, Biotechnology & Life Sciences — 9.3%** | **Pharmaceuticals, Biotechnology & Life Sciences — 9.3%** | **Pharmaceuticals, Biotechnology & Life Sciences — 9.3%** |
| Bristol-Myers Squibb Co. | 1547257 | 76125044 |
| Danaher Corp. | 335864 | 76167238 |
| Gilead Sciences, Inc. | 763549 | 96085006 |
| Jazz Pharmaceuticals PLC<sup>(b)</sup> <br>| 287293 | 50715833 |
| Johnson & Johnson | 1810489 | 374626384 |
| Pfizer, Inc. | 3815367 | 98207547 |
| Thermo Fisher Scientific, Inc. | 290227 | 171474819 |
|  |  | **943401871** |
| **Semiconductors & Semiconductor Equipment — 2.7%** | **Semiconductors & Semiconductor Equipment — 2.7%** | **Semiconductors & Semiconductor Equipment — 2.7%** |
| Applied Materials, Inc. | 897330 | 226351493 |
| Intel Corp.<sup>(b)</sup> <br>| 1294804 | 52517250 |
|  |  | **278868743** |
| **Software & Services — 3.5%** | **Software & Services — 3.5%** | **Software & Services — 3.5%** |
| Akamai Technologies, Inc.<sup>(b)</sup> <br>| 1136324 | 101723724 |
| Check Point Software Technologies Ltd.<sup>(b)</sup> <br>| 262374 | 49003592 |
| Dolby Laboratories, Inc., Cl. A | 1447578 | 97639136 |
| International Business Machines Corp. | 345625 | 106652963 |
|  |  | **355019415** |
| **Technology Hardware & Equipment — 4.4%** | **Technology Hardware & Equipment — 4.4%** | **Technology Hardware & Equipment — 4.4%** |
| Cisco Systems, Inc. | 4611058 | 354774802 |
| TE Connectivity PLC | 435384 | 98462092 |
|  |  | **453236894** |

---

**4**

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 99.1% (continued)** | **Common Stocks — 99.1% (continued)** | **Common Stocks — 99.1% (continued)** |
| **Telecommunication Services — .8%** | **Telecommunication Services — .8%** | **Telecommunication Services — .8%** |
| AT&T, Inc. | 2959201 | **76998410** |
| **Transportation — 3.1%** | **Transportation — 3.1%** | **Transportation — 3.1%** |
| CSX Corp. | 4609948 | 163007761 |
| Delta Air Lines, Inc. | 1514718 | 97093424 |
| FedEx Corp. | 216184 | 59597605 |
|  |  | **319698790** |
| **Utilities — .5%** | **Utilities — .5%** | **Utilities — .5%** |
| Constellation Energy Corp. | 145472 | **53004178** |
| &nbsp;&nbsp;&nbsp; **Total Common Stocks** <br>(cost $8,744,756,101)<br>|  | **10112803359** |
| **Exchange-Traded Funds — .5%** | **Exchange-Traded Funds — .5%** | **Exchange-Traded Funds — .5%** |
| **Registered Investment Companies — .5%** | **Registered Investment Companies — .5%** | **Registered Investment Companies — .5%** |
| &nbsp;&nbsp;&nbsp; iShares Russell 1000 Value ETF <br>(cost $51,043,938)<br>| 243148 | **51056217** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | |
|:---|:---|:---|:---|
|  | 1-Day <br>Yield (%)<br>|  |  |
| **Investment Companies — 1.2%** | **Investment Companies — 1.2%** | **Investment Companies — 1.2%** | **Investment Companies — 1.2%** |
| **Registered Investment Companies — 1.2%** | **Registered Investment Companies — 1.2%** | **Registered Investment Companies — 1.2%** | **Registered Investment Companies — 1.2%** |
| &nbsp;&nbsp;&nbsp; Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional <br> Shares<sup>(d)</sup> <br>(cost $123,309,083)<br>| 4.15 | 123309083 | **123309083** |
| **Total Investments** (cost $8,919,109,122) | **Total Investments** (cost $8,919,109,122) | **100.8%** | **10287168659** |
| **Liabilities, Less Cash and Receivables** | **Liabilities, Less Cash and Receivables** | **(.8%)** | **(84272841)** |
| **Net Assets**  | **Net Assets**  | **100.0%** | **10202895818** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*ETF—Exchange-Traded Fund*<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> *Security, or portion thereof, on loan. At November 30, 2025, the value of the fund's securities on loan was $130,956,860 and the value of the collateral was* *$133,238,427, consisting of U.S. Government & Agency securities. In addition, the value of collateral may include pending sales that are also on loan.* 

<sup>(b)</sup> *Non-income producing security.*

<sup>(c)</sup> *Investment in real estate investment trust within the United States.*

<sup>(d)</sup> *Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's* *prospectus.* 

*See notes to schedule of investments.*

**5**

------

Schedule of Investments

BNY Mellon Dynamic Value Fund

November 30, 2025 (Unaudited)

The following is a summary of the inputs used as of November 30, 2025 in valuing the fund's investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1 -** <br>**Unadjusted** <br>**Quoted Prices**<br>| **Level 2- Other** <br>**Significant** <br>**Observable Inputs**<br>| **Level 3-** <br>**Significant** <br>**Unobservable** <br>**Inputs**<br>| **Total** |
| **Assets ($)** |  |  |  |  |
| Investments in Securities:<sup>†</sup> <br>|  |  |  |  |
| Equity Securities - Common Stocks | &nbsp;&nbsp; 10112803359 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **10112803359** |
| Exchange-Traded Funds | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 51056217 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **51056217** |
| Investment Companies | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 123309083 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **123309083** |
|  | &nbsp;&nbsp; **10287168659** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **10287168659** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>†</sup> *See Schedule of Investments for additional detailed categorizations, if any.*

**6**

------

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") is the exclusive reference of authoritative U.S. generally accepted accounting principles ("GAAP") recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission ("SEC") under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund's financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund's investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

**Level 1**—unadjusted quoted prices in active markets for identical investments.

**Level 2**—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

**Level 3**—significant unobservable inputs (including the fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund's investments are as follows:

The Company's Board of Directors (the "Board") has designated the Adviser as the fund's valuation designee to make all fair value determinations with respect to the fund's portfolio investments, subject to the Board's oversight and pursuant to Rule 2a-5 under the Act.

Investments in equity securities and exchange-traded funds are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. These securities are generally categorized within Level 2 of the fair value hierarchy.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depositary Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded, but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

**7**

------

Pursuant to a securities lending agreement with BNY, the fund may lend securities to qualified institutions. It is the fund's policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by the Adviser, or U.S. Government and Agency securities. The securities on loan, if any, are also disclosed in the fund's Schedule of Investments. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a result of the lending transaction. Should a borrower fail to return the securities in a timely manner, BNY is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund's rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At November 30, 2025, accumulated net unrealized appreciation on investments was $1,368,059,537, consisting of $1,540,920,771 gross unrealized appreciation and $172,861,234 gross unrealized depreciation.

At November 30, 2025, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Schedule of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.

**8**

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** BNY Mellon Advantage Funds, Inc.

- **b. Investment Company Act file number:** 811-07123

- **c. CIK number of Registrant:** 0000914775

- **d. LEI of Registrant:** 549300SWCD16M4CV8Q16

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 240 Greenwich Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10286

  - **Telephone number:** 212-922-6400

**Item A.2. Information about the Series.**

- **a. Name of Series:** BNY Mellon Dynamic Value Fund

- **b. EDGAR series identifier (if any):** S000000498

- **c. LEI of Series:** 549300SDV4Y0Z7K4RZ40

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-08-31

- **b. Date as of which information is reported:** 2025-11-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $10206050709.74

**Total Liabilities:** $6461255.78

**Net Assets:** $10199589453.96

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000001358 | 0.71%                | 0.63%                | 2.52%                |
| Class ID C000001360 | 0.66%                | 0.56%                | 2.46%                |
| Class ID C000001361 | 0.74%                | 0.64%                | 2.54%                |
| Class ID C000130427 | 0.75%                | 0.64%                | 2.54%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $16914153.33             | $44939621.91                               |
| Month 2  | $106245202.70            | $-46436925.68                              |
| Month 3  | $111322463.95            | $123861484.06                              |

### Schedule of Portfolio Investments

| Name                           | Title                                                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Citigroup Inc                  | Citigroup Inc                                                     | CUSIP: 172967424<br>LEI: 6SHGI4ZSSLCXXQSBB395 | Long             | EC               | CORP              | US        |   1912376 | NS      | $198122153.60 | 1.94%             |  |  |  | No            |                  1 | On Loan: No      |
| AT&T Inc                       | AT&T Inc                                                          | CUSIP: 00206R102<br>LEI: 549300Z40J86GGSTL398 | Long             | EC               | CORP              | US        |   2936852 | NS      | $76416889.04  | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Labcorp Holdings Inc           | Labcorp Holdings Inc                                              | CUSIP: 504922105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    227567 | NS      | $61165458.26  | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Diamondback Energy Inc         | Diamondback Energy Inc                                            | CUSIP: 25278X109<br>LEI: 549300R22LSX6OHWEN64 | Long             | EC               | CORP              | US        |    728641 | NS      | $111183330.19 | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Carlisle Cos Inc               | Carlisle Cos Inc                                                  | CUSIP: 142339100<br>LEI: XR64VGX1ZPX6G7ZN7Z11 | Long             | EC               | CORP              | US        |    180092 | NS      | $57281862.44  | 0.56%             |  |  |  | No            |                  1 | On Loan: —       |
| Thermo Fisher Scientific Inc   | Thermo Fisher Scientific Inc                                      | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |    290227 | NS      | $171474818.41 | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Dolby Laboratories Inc         | Dolby Laboratories Inc                                            | CUSIP: 25659T107<br>LEI: 549300X04FB2QPCJ5J24 | Long             | EC               | CORP              | US        |   1436645 | NS      | $96901705.25  | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Check Point Software Technolog | Check Point Software Technologies Ltd                             | CUSIP: 000000000<br>LEI: 2549003ZVBH73EPNS513 | Long             | EC               | CORP              | IL        |    260392 | NS      | $48633413.84  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Veralto Corp                   | Veralto Corp                                                      | CUSIP: 92338C103<br>LEI: 635400FJE6GSOJUSNY27 | Long             | EC               | CORP              | US        |    468957 | NS      | $47467827.54  | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Applied Materials Inc          | Applied Materials Inc                                             | CUSIP: 038222105<br>LEI: 41BNNE1AFPNAZELZ6K07 | Long             | EC               | CORP              | US        |    897330 | NS      | $226351492.50 | 2.22%             |  |  |  | No            |                  1 | On Loan: No      |
| L3Harris Technologies Inc      | L3Harris Technologies Inc                                         | CUSIP: 502431109<br>LEI: 549300UTE50ZMDBG8A20 | Long             | EC               | CORP              | US        |    767628 | NS      | $213930247.32 | 2.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Newmont Corp                   | Newmont Corp                                                      | CUSIP: 651639106<br>LEI: 549300VSP3RIX7FGDZ51 | Long             | EC               | CORP              | US        |   1749290 | NS      | $158713081.70 | 1.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Packaging Corp of America      | Packaging Corp of America                                         | CUSIP: 695156109<br>LEI: 549300XZP8MFZFY8TJ84 | Long             | EC               | CORP              | US        |    547405 | NS      | $111708938.35 | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Walt Disney Co/The             | Walt Disney Co/The                                                | CUSIP: 254687106<br>LEI: 549300GZKULIZ0WOW665 | Long             | EC               | CORP              | US        |    848610 | NS      | $88654286.70  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Hubbell Inc                    | Hubbell Inc                                                       | CUSIP: 443510607<br>LEI: 54930088VDQ6840Y6597 | Long             | EC               | CORP              | US        |    284887 | NS      | $122908798.41 | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Delta Air Lines Inc            | Delta Air Lines Inc                                               | CUSIP: 247361702<br>LEI: Q2CCMS6R0AS67HJMBN42 | Long             | EC               | CORP              | US        |   1511555 | NS      | $96890675.50  | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Berkshire Hathaway Inc         | Berkshire Hathaway Inc                                            | CUSIP: 084670702<br>LEI: 5493000C01ZX7D35SD85 | Long             | EC               | CORP              | US        |    810633 | NS      | $416511341.73 | 4.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Honeywell International Inc    | Honeywell International Inc                                       | CUSIP: 438516106<br>LEI: ISRPG12PN4EIEOEMW547 | Long             | EC               | CORP              | US        |    535198 | NS      | $102859703.62 | 1.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Emerson Electric Co            | Emerson Electric Co                                               | CUSIP: 291011104<br>LEI: FGLT0EWZSUIRRITFOA30 | Long             | EC               | CORP              | US        |    623419 | NS      | $83151626.22  | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Las Vegas Sands Corp           | Las Vegas Sands Corp                                              | CUSIP: 517834107<br>LEI: 549300DUOO1KXOHPM605 | Long             | EC               | CORP              | US        |   1470892 | NS      | $100255998.72 | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC       | Jazz Pharmaceuticals PLC                                          | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |    286881 | NS      | $50643102.93  | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Alcoa Corp                     | Alcoa Corp                                                        | CUSIP: 013872106<br>LEI: 549300T12EZ1F6PWWU29 | Long             | EC               | CORP              | US        |   1564631 | NS      | $65307697.94  | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| CRH PLC                        | CRH PLC                                                           | CUSIP: 000000000<br>LEI: 549300MIDJNNTH068E74 | Long             | EC               | CORP              | IE        |   1930456 | NS      | $231577501.76 | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc            | Elevance Health Inc                                               | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |    300102 | NS      | $101512502.52 | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Phillips 66                    | Phillips 66                                                       | CUSIP: 718546104<br>LEI: 5493005JBO5YSIGK1814 | Long             | EC               | CORP              | US        |   1367490 | NS      | $187291430.40 | 1.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Permian Resources Corp         | Permian Resources Corp                                            | CUSIP: 71424F105<br>LEI: 529900NXUJPOKU7OJ511 | Long             | EC               | CORP              | US        |   6830168 | NS      | $98969134.32  | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Marathon Petroleum Corp        | Marathon Petroleum Corp                                           | CUSIP: 56585A102<br>LEI: 3BNYRYQHD39K4LCKQF12 | Long             | EC               | CORP              | US        |   1042592 | NS      | $201981348.16 | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Morgan Stanley                 | Morgan Stanley                                                    | CUSIP: 617446448<br>LEI: IGJSJL3JD5P30I6NJZ34 | Long             | EC               | CORP              | US        |    988672 | NS      | $167738091.52 | 1.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                  | Medtronic PLC                                                     | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |   2812577 | NS      | $296248735.41 | 2.90%             |  |  |  | No            |                  1 | On Loan: No      |
| CSX Corp                       | CSX Corp                                                          | CUSIP: 126408103<br>LEI: 549300JVQR4N1MMP3Q88 | Long             | EC               | CORP              | US        |   4575130 | NS      | $161776596.80 | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Group Inc/The    | Goldman Sachs Group Inc/The                                       | CUSIP: 38141G104<br>LEI: 784F5XWPLTWKTBV3E584 | Long             | EC               | CORP              | US        |    155766 | NS      | $128668946.64 | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Cummins Inc                    | Cummins Inc                                                       | CUSIP: 231021106<br>LEI: ZUNI8PYC725B6H8JU438 | Long             | EC               | CORP              | US        |    164537 | NS      | $81936135.26  | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Ferguson Enterprises Inc       | Ferguson Enterprises Inc                                          | CUSIP: 31488V107<br>LEI: 2138003JYQMRP3SLX189 | Long             | EC               | CORP              | US        |    292134 | NS      | $73521363.78  | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphabet Inc                   | Alphabet Inc                                                      | CUSIP: 02079K305<br>LEI: 5493006MHB84DD0ZWV18 | Long             | EC               | CORP              | US        |    782640 | NS      | $250585675.20 | 2.46%             |  |  |  | No            |                  1 | On Loan: No      |
| JPMorgan Chase & Co            | JPMorgan Chase & Co                                               | CUSIP: 46625H100<br>LEI: 8I5DZWZKVSZI1NUHU748 | Long             | EC               | CORP              | US        |   1123797 | NS      | $351838364.76 | 3.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                     | Humana Inc                                                        | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |    456197 | NS      | $112119536.69 | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| TE Connectivity PLC            | TE Connectivity PLC                                               | CUSIP: 000000000<br>LEI: 6367003TB6K484NFHE54 | Long             | EC               | CORP              | IE        |    433860 | NS      | $98117439.00  | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| American International Group I | American International Group Inc                                  | CUSIP: 026874784<br>LEI: ODVCVCQG2BP6VHV36M30 | Long             | EC               | CORP              | US        |   1385966 | NS      | $105555170.56 | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Alcon AG                       | Alcon AG                                                          | CUSIP: 000000000<br>LEI: 549300LDT5AP8S0NBM78 | Long             | EC               | CORP              | CH        |    873349 | NS      | $69265309.19  | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                   | Danaher Corp                                                      | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    335353 | NS      | $76051353.34  | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Amazon.com Inc                 | Amazon.com Inc                                                    | CUSIP: 023135106<br>LEI: ZXTILKJKG63JELOEG630 | Long             | EC               | CORP              | US        |    916897 | NS      | $213838718.34 | 2.10%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc         | UnitedHealth Group Inc                                            | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    536694 | NS      | $176985580.38 | 1.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Constellation Energy Corp      | Constellation Energy Corp                                         | CUSIP: 21037T109<br>LEI: 549300F8Y20RYGNGV346 | Long             | EC               | CORP              | US        |    144888 | NS      | $52791391.68  | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc            | Gilead Sciences Inc                                               | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    757783 | NS      | $95359412.72  | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Northrop Grumman Corp          | Northrop Grumman Corp                                             | CUSIP: 666807102<br>LEI: RIMU48P07456QXSO0R61 | Long             | EC               | CORP              | US        |    179776 | NS      | $102876816.00 | 1.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                     | Pfizer Inc                                                        | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   3800769 | NS      | $97831794.06  | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Capital One Financial Corp     | Capital One Financial Corp                                        | CUSIP: 14040H105<br>LEI: ZUE8T73ROZOF6FLBAR73 | Long             | EC               | CORP              | US        |    478884 | NS      | $104909117.88 | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Howmet Aerospace Inc           | Howmet Aerospace Inc                                              | CUSIP: 443201108<br>LEI: 549300HO5WFZUT5N2T22 | Long             | EC               | CORP              | US        |    267600 | NS      | $54748284.00  | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| EQT Corp                       | EQT Corp                                                          | CUSIP: 26884L109<br>LEI: 4NT01YGM4X7ZX86ISY52 | Long             | EC               | CORP              | US        |   1851274 | NS      | $112668535.64 | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Cisco Systems Inc              | Cisco Systems Inc                                                 | CUSIP: 17275R102<br>LEI: 549300LKFJ962MZ46593 | Long             | EC               | CORP              | US        |   4593465 | NS      | $353421197.10 | 3.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Lowe's Cos Inc                 | Lowe's Cos Inc                                                    | CUSIP: 548661107<br>LEI: WAFCR4OKGSC504WU3E95 | Long             | EC               | CORP              | US        |    428165 | NS      | $103821449.20 | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| DREYFUS INSTITUTIONAL PREFERRE | DREYFUS INSTITUTIONAL PREFERRED GOVERNMENT PLUS MONEY MARKET FUND | CUSIP: 000000000<br>LEI: 549300RBWL04JG8SIX57 | Long             | STIV             | RF                | US        | 123309083 | NS      | $123309082.90 | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Assurant Inc                   | Assurant Inc                                                      | CUSIP: 04621X108<br>LEI: H3F39CAXWQRVWURFXL38 | Long             | EC               | CORP              | US        |   1319524 | NS      | $301062595.84 | 2.95%             |  |  |  | No            |                  1 | On Loan: No      |
| First Horizon Corp             | First Horizon Corp                                                | CUSIP: 320517105<br>LEI: TF3RXI1ZB1TQ30H9JV10 | Long             | EC               | CORP              | US        |   6757105 | NS      | $150953725.70 | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| CME Group Inc                  | CME Group Inc                                                     | CUSIP: 12572Q105<br>LEI: LCZ7XYGSLJUHFXXNXD88 | Long             | EC               | CORP              | US        |    391877 | NS      | $110297700.42 | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Bank of America Corp           | Bank of America Corp                                              | CUSIP: 060505104<br>LEI: 9DJT3UXIJIZJI4WXO774 | Long             | EC               | CORP              | US        |   4991485 | NS      | $267793170.25 | 2.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co        | Bristol-Myers Squibb Co                                           | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |   1535572 | NS      | $75550142.40  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Meta Platforms Inc             | Meta Platforms Inc                                                | CUSIP: 30303M102<br>LEI: BQ4BKCS1HXDV9HN80Z93 | Long             | EC               | CORP              | US        |     76243 | NS      | $49401651.85  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson              | Johnson & Johnson                                                 | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |   1900195 | NS      | $393188349.40 | 3.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Aon PLC                        | Aon PLC                                                           | CUSIP: 000000000<br>LEI: 635400FALWQYX5E6QC64 | Long             | EC               | CORP              | GB        |    595609 | NS      | $210797937.28 | 2.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Estee Lauder Cos Inc/The       | Estee Lauder Cos Inc/The                                          | CUSIP: 518439104<br>LEI: 549300VFZ8XJ9NUPU221 | Long             | EC               | CORP              | US        |   1072916 | NS      | $100929208.12 | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Voya Financial Inc             | Voya Financial Inc                                                | CUSIP: 929089100<br>LEI: 549300T065Z4KJ686G75 | Long             | EC               | CORP              | US        |   1570779 | NS      | $110425763.70 | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Exxon Mobil Corp               | Exxon Mobil Corp                                                  | CUSIP: 30231G102<br>LEI: J3WHBG0MTS7O8ZVMDC91 | Long             | EC               | CORP              | US        |   2269568 | NS      | $263088322.56 | 2.58%             |  |  |  | No            |                  1 | On Loan: No      |
| FedEx Corp                     | FedEx Corp                                                        | CUSIP: 31428X106<br>LEI: 549300E707U7WNPZN687 | Long             | EC               | CORP              | US        |    214551 | NS      | $59147419.68  | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Akamai Technologies Inc        | Akamai Technologies Inc                                           | CUSIP: 00971T101<br>LEI: OC1LZNN2LF5WTJ5RIL89 | Long             | EC               | CORP              | US        |   1136324 | NS      | $101723724.48 | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Omnicom Group Inc              | Omnicom Group Inc                                                 | CUSIP: 681919106<br>LEI: HKUPACFHSSASQK8HLS17 | Long             | EC               | CORP              | US        |   1932110 | NS      | $138377718.20 | 1.36%             |  |  |  | No            |                  1 | On Loan: —       |
| Intel Corp                     | Intel Corp                                                        | CUSIP: 458140100<br>LEI: KNX4USFCNGPY45LOCE31 | Long             | EC               | CORP              | US        |   1285025 | NS      | $52120614.00  | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Charles Schwab Corp/The        | Charles Schwab Corp/The                                           | CUSIP: 808513105<br>LEI: 549300VSGCJ7E698NM85 | Long             | EC               | CORP              | US        |    518578 | NS      | $48087737.94  | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Freeport-McMoRan Inc           | Freeport-McMoRan Inc                                              | CUSIP: 35671D857<br>LEI: 549300IRDTHJQ1PVET45 | Long             | EC               | CORP              | US        |   3425496 | NS      | $147227818.08 | 1.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Caterpillar Inc                | Caterpillar Inc                                                   | CUSIP: 149123101<br>LEI: WRJR7GS4GTRECRRTVX92 | Long             | EC               | CORP              | US        |    231063 | NS      | $133036832.88 | 1.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp      | Edwards Lifesciences Corp                                         | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    837019 | NS      | $72544436.73  | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Weyerhaeuser Co                | Weyerhaeuser Co                                                   | CUSIP: 962166104<br>LEI: 08IRJODWFYBI7QWRGS31 | Long             | EC               | CORP              | US        |   4604981 | NS      | $102276628.01 | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Dover Corp                     | Dover Corp                                                        | CUSIP: 260003108<br>LEI: 549300FMC2ALGA7N9E80 | Long             | EC               | CORP              | US        |    269387 | NS      | $49912023.36  | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Royal Caribbean Cruises Ltd    | Royal Caribbean Cruises Ltd                                       | CUSIP: 000000000<br>LEI: K2NEH8QNVW44JIWK7Z55 | Long             | EC               | CORP              | US        |    179974 | NS      | $47918077.50  | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| IBM                            | International Business Machines Corp                              | CUSIP: 459200101<br>LEI: VGRQXHF3J8VDLUA7XE92 | Long             | EC               | CORP              | US        |    344309 | NS      | $106246871.22 | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-01-23

**Name of Applicant:** BNY Mellon Advantage Funds, Inc.

**Signature:** James Windels

**Name of Signer:** James Windels

**Title:** Treasurer